Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1615 1626
This examiner grants 72% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18495023 | DEODORANT COMPOSITIONS WITH NATURAL WAX | Non-Final OA | The Procter & Gamble Company |
| 17961089 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | Non-Final OA | The Procter & Gamble Company |
| 18036209 | DELAYED RELEASE SOFTGEL CAPSULES | Non-Final OA | R.P. Scherer Technologies, LLC |
| 18547596 | ANTIMICROBIAL WET WIPES | Final Rejection | Kimberly-Clark Worldwide, Inc. |
| 18347181 | COMPOSITIONS AND DEVICES INCORPORATING WATER-INSOLUBLE THERAPEUTIC AGENTS AND METHODS OF THE USE THEREOF | Non-Final OA | COOK MEDICAL TECHNOLOGIES LLC |
| 18563327 | HARD-SHELL CAPSULE WITH INFLUX PREVENTION OF GASTRIC FLUIDS | Non-Final OA | Evonik Operations GmbH |
| 18485737 | PHOTOTRIGGERABLE NITRIC OXIDE-RELEASING COMPOSITIONS AND APPLICATIONS THEREOF | Non-Final OA | University of Georgia Research Foundation, Inc. |
| 18251428 | Oral Hydrogel Compositions and Uses | Non-Final OA | Colgate-Palmolive Company |
| 18139195 | PARENTERAL NUTRITION FORMULATION | Final Rejection | BAXTER HEALTHCARE SA |
| 18036141 | TALAZOPARIB SOFT GELATIN CAPSULE DOSAGE FORM | Final Rejection | PFIZER INC. |
| 18649055 | METAL (HYDR) OXIDE COMPOSITE COMPRISING POORLY SOLUBLE DRUG, METHOD FOR MANUFACTURING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Final Rejection | CNPHARM CO., LTD. |
| 18624478 | BIOABSORBABLE POLYMERIC COMPOSITION FOR A MEDICAL DEVICE | Non-Final OA | ORBUSNEICH MEDICAL PTE. LTD. |
| 17599811 | LONG-LASTING COSMETIC COMPOSITION | Non-Final OA | ROQUETTE FRERES |
| 17310238 | SUNSCREEN COMPOSITIONS | Final Rejection | BEIERSDORF AG |
| 17760866 | BIOACTIVE IMPLANTS FOR DRUG DELIVERY | Non-Final OA | The Queen's University of Belfast |
| 18005843 | USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES | Final Rejection | Jazz Pharmaceuticals Research UK Limited |
| 18317625 | MULTI-PARTICULATE PHARMACEUTICAL COMPOSITION OF QUETIAPINE | Non-Final OA | Sun Pharmaceutical Industries Limited |
| 18131908 | PLANT-BASED HARD CAPSULE FOR RAPID DISINTEGRATION AND METHOD THEREOF | Non-Final OA | HUAQIAO UNIVERSITY |
| 18568694 | NON-NANOPARTICULATE APPLICATION FORMS OF MACROLIDES | Non-Final OA | Nucleus Medical GmbH |
| 18246582 | GASTRO RETENTIVE DOSAGE FORMS COMPRISING DEUTETRABENAZINE | Final Rejection | AUSPEX PHARMACEUTICALS, INC. |
| 18539830 | METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT | Final Rejection | Acura Pharmaceuticals, Inc. |
| 18556142 | Drug Delivery System for Medical Devices | Non-Final OA | Rontis Hellas S.A. |
| 18286433 | COMPOSITIONS | Non-Final OA | VITUX GROUP AS |
| 18370572 | RESCUE COMPOSITIONS FOR HYPOGLYCEMIA | Non-Final OA | Empire Drying Services LLC |
| 18240284 | DRUG DELIVERY SYSTEM FOR ULTRA-LOW DOSE ESTROGEN COMBINATIONS AND METHODS AND USES THEREOF | Final Rejection | LUPIN INC. |
| 18454139 | BORONATED NANOSCALE SUBSTRATE AND USES THEREOF | Final Rejection | SAN JOSE STATE UNIVERSITY RESEARCH FOUNDATION |
| 18265987 | SELF-SUSTAINED RELEASE IMMUNE ADJUVANT SUSPENSION, PREPARATION METHOD THEREFOR, AND USE THEREOF | Non-Final OA | INNOBM PHARMACEUTICALS CO., LTD. |
| 17794886 | TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING THE INGREDIENT ROTIGOTINE AND AT LEAST ONE NON-AMINE-RESISTANT SILICONE ADHESIVE | Non-Final OA | Luye Pharma Switzerland AG |
| 17971462 | COMPOSITION, ARTICLE AND METHOD FOR AFFECTING A MAMMAL | Non-Final OA | COOLHOUSE SOURCING LLC |
| 17614076 | METHOD FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING AMPHIPHILIC ACTIVE INGREDIENTS | Non-Final OA | PHARMADEV SA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy